New drug trial aims to protect insulin cells in type 1 diabetes
Disease control
Recruiting now
This study is testing an oral drug called DFMO to see if it can protect the body's remaining insulin-producing cells in people recently diagnosed with type 1 diabetes. About 70 participants will take either DFMO or a placebo pill twice daily for six months. Researchers will measu…
Phase: PHASE2 • Sponsor: Emily K. Sims • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC